Your browser doesn't support javascript.
loading
Multidisciplinary treatment of primary intracranial yolk sac tumor: A case report and literature review.
Xu, Zhen-Ning; Yue, Xiang-Yong; Cao, Xiao-Ci; Liu, Ya-Dong; Fang, Bao-Shuan; Zhao, Wen-Hao; Li, Chen; Xu, Shuai; Zhang, Ming.
Afiliação
  • Xu ZN; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Yue XY; Graduate School of North China University of Science and Technology, Tangshan, China.
  • Cao XC; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Liu YD; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Fang BS; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Zhao WH; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Li C; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Xu S; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
  • Zhang M; Department of Radiation Oncology, Hebei General Hospital, Shijiazhuang.
Medicine (Baltimore) ; 100(19): e25778, 2021 May 14.
Article em En | MEDLINE | ID: mdl-34106610
ABSTRACT
RATIONALE Intracranial yolk sac tumors (YSTs) are rare malignancies with limited treatment options and a dismal prognosis. They are usually managed with surgical resection and chemoradiotherapy. PATIENT CONCERNS Here, we report a patient with primary YST in the pineal region who achieved long term survival. Despite undergoing treatment, he experienced several recurrences over a 15-year period. DIAGNOSIS Brain magnetic resonance imaging (MRI) demonstrated the presence of space-occupying lesions in the pineal region and the medial tail of the left lateral ventricle. The tumors were excised, and the histological diagnosis suggested an intracranial YST.

INTERVENTIONS:

The patient achieved long term survival after combined modality therapy including surgery, stereotactic radiosurgery (SRS)/intensity modulated radiation therapy (IMRT), chemotherapy, and targeted therapy.

OUTCOMES:

The disease remained stable. However, the patient gave up treatment and passed away in October 2020, with a total survival of about 15 years. LESSONS To the best of our knowledge, this patient with intracranial YST had received a longer survival compared with other published reports. We summarize previously published reports of intracranial YST and discuss the importance of multidisciplinary treatment. SRS may have a role, as a focal boost to residual tumor after resection or in case of recurrence after conventional radiotherapy, in the multimodality management of intracranial YSTs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Glândula Pineal / Neoplasias Encefálicas / Tumor do Seio Endodérmico / Ventrículos Laterais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equipe de Assistência ao Paciente / Glândula Pineal / Neoplasias Encefálicas / Tumor do Seio Endodérmico / Ventrículos Laterais Idioma: En Ano de publicação: 2021 Tipo de documento: Article